+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Diabetes Care Devices Market - Global Forecast 2026-2032- Product Image
Diabetes Care Devices Market - Global Forecast 2026-2032- Product Image
Sale

Diabetes Care Devices Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5311206
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Diabetes Care Devices Market is projected to reach USD 36.34 Billion in 2026. It is expected to continue growing at a CAGR of 13.42%, reaching USD 77.72 Billion by 2032.

Diabetes care devices are moving from episodic monitoring tools to connected, data-enabled systems that support continuous diabetes management across home, clinic, pharmacy, and hospital settings. The category includes blood glucose monitoring systems, continuous glucose monitors, insulin pens, insulin pumps, smart pen caps, lancets, infusion sets, and integrated digital platforms.

Demand is supported by the global diabetes burden. The International Diabetes Federation estimates that 537 million adults were living with diabetes in 2021 and projects 783 million by 2045. This sustained clinical need is accelerating adoption of continuous glucose monitoring, automated insulin delivery, and interoperable diabetes technology designed to improve glycemic control, reduce hypoglycemia risk, and support value-based care.

Transformative Shifts in Diabetes Device Adoption

The diabetes care devices landscape is being reshaped by the shift from reactive treatment to proactive, personalized disease management. Continuous glucose monitoring is expanding beyond type 1 diabetes into insulin-treated type 2 diabetes, gestational diabetes risk management, and hospital-to-home follow-up models. Reimbursement expansion, pharmacy distribution, and consumer-friendly sensor design are reducing access barriers.

Interoperability is another structural shift. Regulatory pathways such as the U.S. FDA’s integrated continuous glucose monitoring designation and alternate controller enabled infusion pump framework have encouraged device ecosystems that combine sensors, pumps, algorithms, and mobile applications. Manufacturers are competing on accuracy, wear duration, ease of insertion, data security, cloud connectivity, and integration with electronic health records.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is increasing the clinical value of diabetes care devices by turning high-frequency glucose, insulin, meal, activity, and sleep data into timely insights. In automated insulin delivery, algorithms help adjust basal insulin and correction dosing based on sensor glucose trends, supporting improved time in range when used appropriately under clinical guidance.

AI-enabled analytics also support remote patient monitoring, population risk stratification, personalized coaching, and early detection of adherence gaps. The cumulative impact is a move toward predictive diabetes management; however, industry leaders must validate algorithms across diverse populations, address bias, maintain cybersecurity, and comply with evolving medical device software requirements.

Key Regional Insights for Diabetes Care Devices

Asia-Pacific is a major diabetes care devices region due to large diabetes populations in China and India, rising healthcare expenditure, expanding pharmacy access, and broader availability of connected glucose monitoring. Japan, South Korea, and Australia show strong uptake of advanced diabetes technology due to established reimbursement pathways, clinician familiarity with sensor-based care, and digital health infrastructure supporting remote monitoring.

North America remains a leading innovation and commercialization hub, supported by FDA-cleared continuous glucose monitoring and automated insulin delivery systems, strong payer coverage for insulin users, high smartphone penetration, and broad adoption of digital health workflows. Europe benefits from national health systems, CE-marked technologies, structured diabetes programs, and growing emphasis on real-world evidence under stricter device regulation. Latin America shows rising demand for affordable glucose meters, strips, insulin delivery supplies, and selective CGM access, with Brazil and Mexico anchoring regional adoption. The Middle East is advancing diabetes prevention, screening, and connected care initiatives, particularly across high-income Gulf health systems. Africa continues to face affordability, distribution, and specialist access constraints, making essential blood glucose monitoring, test strips, and reliable insulin delivery supplies central to diabetes care priorities.

Key Group Insights Across Global Health Economies

ASEAN markets are expanding through urban healthcare investment, pharmacy-led access, private insurance uptake, and rising awareness of diabetes self-management, although reimbursement remains uneven across member states. The GCC is prioritizing diabetes technology as part of broader noncommunicable disease strategies, supported by high diabetes prevalence, government-backed digital transformation, and increasing deployment of connected care models in public and private healthcare systems.

The European Union benefits from regulatory harmonization under the Medical Device Regulation, cross-border clinical evidence expectations, and established public reimbursement mechanisms, while manufacturers face stronger requirements for clinical evaluation, post-market surveillance, and data protection. BRICS countries represent significant patient-access opportunities because of large diabetes populations, led by China, India, and Brazil, with procurement, affordability, and local manufacturing policies influencing adoption. G7 markets are central to premium device adoption, reimbursement evidence generation, and clinical guideline integration. NATO countries overlap heavily with advanced reimbursement systems and regulated medtech supply chains, increasing the importance of cybersecurity, continuity of supply, and data governance for connected diabetes care devices.

Key Country Insights for Priority Device Markets

The United States leads in diabetes care device innovation, reimbursement depth, and use of continuous glucose monitoring and automated insulin delivery, with the CDC reporting 38.4 million Americans with diabetes. Canada shows steady uptake supported by provincial coverage variability and specialist-driven diabetes programs, while Mexico and Brazil present expanding demand for affordable glucose monitoring, insulin delivery solutions, and broader pharmacy availability.

In Europe, the United Kingdom, Germany, France, Italy, and Spain are advancing sensor-based diabetes management through public health systems, clinical guidelines, and structured chronic disease programs, although reimbursement rules and eligibility criteria differ by country. Russia remains a complex market due to procurement dynamics, regulatory considerations, and supply continuity. In Asia-Pacific, China and India offer scale supported by large diabetes populations and expanding domestic healthcare capacity, Japan prioritizes quality, accuracy, and reimbursement-supported innovation, Australia has strong diabetes technology access programs, and South Korea combines advanced digital health capability with rising adoption of connected glucose monitoring and insulin delivery devices.

Actionable Recommendations for Device Leaders

Industry leaders should prioritize evidence-backed product differentiation, especially accuracy, usability, wear time, interoperability, and measurable outcomes such as improved time in range, fewer hypoglycemic events, and lower acute-care utilization. Building clinical evidence across type 1 diabetes, insulin-treated type 2 diabetes, pregnancy-related use cases, pediatrics, and older adults can strengthen payer acceptance and clinician confidence.

Companies should also localize affordability strategies through tiered portfolios, pharmacy distribution, subscription models, patient support services, and partnerships with telehealth providers. Cybersecurity, data privacy, regulatory readiness, human factors engineering, and responsible AI governance must be embedded early in product development to protect patient trust and reduce commercialization risk.

Research Methodology

This executive assessment is structured around verified public health indicators, regulatory developments, clinical adoption patterns, reimbursement dynamics, and technology trends affecting diabetes care devices. Sources typically evaluated include international diabetes burden data, national health agencies, regulator guidance, peer-reviewed clinical evidence, clinical practice recommendations, and public product clearances.

The methodology emphasizes triangulation across demand drivers, device utilization trends, regional access conditions, and health system priorities. Market interpretation focuses on practical decision-making for manufacturers, distributors, providers, payers, and investors while avoiding unsupported claims and separating established trends from emerging opportunities.

Conclusion

The diabetes care devices landscape is entering a more connected, intelligent, and outcomes-oriented phase. Continuous glucose monitoring, smart insulin delivery, digital coaching, and AI-enabled analytics are redefining how patients and clinicians manage daily glycemic decisions.

Long-term progress will depend on clinical validation, affordability, regulatory compliance, equitable access, cybersecurity, and seamless integration into care pathways. Organizations that combine device reliability with actionable data, strong reimbursement evidence, and patient-centered design will be best positioned to lead the next generation of diabetes management.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Diabetes Care Devices Market, by Device Type
7.1. Introduction
7.2. Artificial Pancreas Systems
7.2.1. Full Closed Loop
7.2.2. Hybrid Closed Loop
7.3. Glucose Monitoring Devices
7.3.1. Continuous Glucose Monitoring
7.3.2. Flash Glucose Monitoring
7.3.3. Self Monitoring Blood Glucose
7.4. Injection Aids
7.4.1. Infusion Sets
7.4.2. Pen Needles
7.4.3. Syringe Needles
7.5. Insulin Pens
7.5.1. Prefilled Disposable Pens
7.5.2. Reusable Pens
7.5.3. Smart Pens
7.6. Insulin Pumps
7.6.1. Patch Pumps
7.6.2. Tubed Pumps
7.7. Insulin Syringes
8. Diabetes Care Devices Market, by Technology
8.1. Introduction
8.2. Continuous Glucose Monitoring
8.2.1. Real Time Continuous Glucose Monitoring
8.2.2. Retrospective Continuous Glucose Monitoring
8.3. Flash Glucose Monitoring
8.4. Self Monitoring Blood Glucose
8.4.1. Glucose Meters
8.4.2. Lancets
8.4.3. Test Strips
9. Diabetes Care Devices Market, by Delivery Mode
9.1. Introduction
9.2. Continuous Delivery
9.3. Intermittent Delivery
10. Diabetes Care Devices Market, by Insulin Type
10.1. Introduction
10.2. Intermediate Acting
10.3. Long Acting
10.3.1. Detemir
10.3.2. Glargine
10.4. Rapid Acting
10.4.1. Aspart
10.4.2. Glulisine
10.4.3. Lispro
10.5. Short Acting
10.6. Ultra Long Acting
11. Diabetes Care Devices Market, by Distribution Channel
11.1. Introduction
11.2. Online Channels
11.3. Offline
11.3.1. Retail Pharmacies
11.3.2. Hospital Pharmacies
12. Diabetes Care Devices Market, by End User
12.1. Introduction
12.2. Diagnostic Centers
12.3. Home Care
12.4. Hospitals And Clinics
12.4.1. Diabetes Clinics
12.4.2. General Clinics
13. Diabetes Care Devices Market, by Region
13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa
14. Diabetes Care Devices Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Diabetes Care Devices Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. Acon Laboratories Inc.
17.3. ARKray Inc.
17.4. Ascensia Diabetes Care Holdings AG
17.5. B. Braun Melsungen AG
17.6. Becton Dickinson and Company BD
17.7. Bionime Corporation
17.8. Dexcom Inc.
17.9. Eli Lilly and Company
17.10. F. Hoffmann-La Roche Ltd.
17.11. Insulet Corporation
17.12. LifeScan Inc.
17.13. Medtronic plc
17.14. Menarini Diagnostics
17.15. MicroTech Medical Inc.
17.16. Nipro Corporation
17.17. Novo Nordisk A/S
17.18. Sanofi
17.19. Senseonics Holdings Inc.
17.20. Sinocare
17.21. Tandem Diabetes Care Inc.
17.22. Terumo Corporation
17.23. Trividia Health
17.24. Valeritas Holdings Inc.
17.25. Ypsomed Holding AG
List of Figures
FIGURE 1. GLOBAL DIABETES CARE DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL DIABETES CARE DEVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL DIABETES CARE DEVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL DIABETES CARE DEVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL DIABETES CARE DEVICES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 15. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL DIABETES CARE DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL DIABETES CARE DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL DIABETES CARE DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL DIABETES CARE DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL ARTIFICIAL PANCREAS SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL ARTIFICIAL PANCREAS SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL ARTIFICIAL PANCREAS SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL FULL CLOSED LOOP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL FULL CLOSED LOOP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL FULL CLOSED LOOP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL HYBRID CLOSED LOOP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL HYBRID CLOSED LOOP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL HYBRID CLOSED LOOP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL FLASH GLUCOSE MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL FLASH GLUCOSE MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL FLASH GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL SELF MONITORING BLOOD GLUCOSE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL SELF MONITORING BLOOD GLUCOSE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL SELF MONITORING BLOOD GLUCOSE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL INJECTION AIDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL INJECTION AIDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL INJECTION AIDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL INFUSION SETS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL INFUSION SETS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL INFUSION SETS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL PEN NEEDLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL PEN NEEDLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL PEN NEEDLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL SYRINGE NEEDLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL SYRINGE NEEDLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL SYRINGE NEEDLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL INSULIN PENS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL INSULIN PENS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL INSULIN PENS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL PREFILLED DISPOSABLE PENS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL PREFILLED DISPOSABLE PENS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL PREFILLED DISPOSABLE PENS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL REUSABLE PENS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL REUSABLE PENS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL REUSABLE PENS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL SMART PENS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL SMART PENS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL SMART PENS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL INSULIN PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL INSULIN PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL PATCH PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL PATCH PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL PATCH PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL TUBED PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL TUBED PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL TUBED PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL INSULIN SYRINGES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL INSULIN SYRINGES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL INSULIN SYRINGES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL REAL TIME CONTINUOUS GLUCOSE MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL REAL TIME CONTINUOUS GLUCOSE MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL REAL TIME CONTINUOUS GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL RETROSPECTIVE CONTINUOUS GLUCOSE MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL RETROSPECTIVE CONTINUOUS GLUCOSE MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL RETROSPECTIVE CONTINUOUS GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL FLASH GLUCOSE MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL FLASH GLUCOSE MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL FLASH GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL SELF MONITORING BLOOD GLUCOSE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL SELF MONITORING BLOOD GLUCOSE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL SELF MONITORING BLOOD GLUCOSE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL GLUCOSE METERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL GLUCOSE METERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL GLUCOSE METERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL LANCETS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL LANCETS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL LANCETS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL TEST STRIPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL TEST STRIPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL TEST STRIPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL CONTINUOUS DELIVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL CONTINUOUS DELIVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL CONTINUOUS DELIVERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL INTERMITTENT DELIVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL INTERMITTENT DELIVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL INTERMITTENT DELIVERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL INTERMEDIATE ACTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL INTERMEDIATE ACTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL INTERMEDIATE ACTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL LONG ACTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL LONG ACTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL LONG ACTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL DETEMIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL DETEMIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL DETEMIR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL GLARGINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL GLARGINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL GLARGINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL RAPID ACTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL RAPID ACTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL RAPID ACTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL ASPART MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL ASPART MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL ASPART MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL GLULISINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL GLULISINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL GLULISINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL LISPRO MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL LISPRO MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL LISPRO MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL SHORT ACTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL SHORT ACTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL SHORT ACTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL ULTRA LONG ACTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL ULTRA LONG ACTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL ULTRA LONG ACTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL ONLINE CHANNELS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL ONLINE CHANNELS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL ONLINE CHANNELS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL DIABETES CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL DIABETES CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL DIABETES CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL GENERAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 151. GLOBAL GENERAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 152. GLOBAL GENERAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2017-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2017-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2017-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2017-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2017-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2017-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2017-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 170. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2017-2032 (USD MILLION)
TABLE 172. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 173. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 174. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2017-2032 (USD MILLION)
TABLE 175. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 176. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2017-2032 (USD MILLION)
TABLE 177. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2017-2032 (USD MILLION)
TABLE 178. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 179. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 180. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2017-2032 (USD MILLION)
TABLE 181. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2017-2032 (USD MILLION)
TABLE 182. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 183. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 184. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2017-2032 (USD MILLION)
TABLE 185. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2017-2032 (USD MILLION)
TABLE 186. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 187. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 188. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 189. NORTH AMERICA DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2017-2032 (USD MILLION)
TABLE 190. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 191. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 192. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2017-2032 (USD MILLION)
TABLE 193. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 194. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2017-2032 (USD MILLION)
TABLE 195. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2017-2032 (USD MILLION)
TABLE 196. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 197. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 198. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2017-2032 (USD MILLION)
TABLE 199. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2017-2032 (USD MILLION)
TABLE 200. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 201. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 202. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2017-2032 (USD MILLION)
TABLE 203. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2017-2032 (USD MILLION)
TABLE 204. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 205. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 206. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 207. LATIN AMERICA DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2017-2032 (USD MILLION)
TABLE 208. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 209. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 210. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2017-2032 (USD MILLION)
TABLE 211. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 212. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2017-2032 (USD MILLION)
TABLE 213. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2017-2032 (USD MILLION)
TABLE 214. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 215. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 216. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2017-2032 (USD MILLION)
TABLE 217. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2017-2032 (USD MILLION)
TABLE 218. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 219. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 220. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2017-2032 (USD MILLION)
TABLE 221. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2017-2032 (USD MILLION)
TABLE 222. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 223. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 224. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 225. EUROPE DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2017-2032 (USD MILLION)
TABLE 226. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 227. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 228. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2017-2032 (USD MILLION)
TABLE 229. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 230. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2017-2032 (USD MILLION)
TABLE 231. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2017-2032 (USD MILLION)
TABLE 232. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 233. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 234. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2017-2032 (USD MILLION)
TABLE 235. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2017-2032 (USD MILLION)
TABLE 236. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 237. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 238. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2017-2032 (USD MILLION)
TABLE 239. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2017-2032 (USD MILLION)
TABLE 240. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 241. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 242. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 243. MIDDLE EAST DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2017-2032 (USD MILLION)
TABLE 244. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 245. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 246. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2017-2032 (USD MILLION)
TABLE 247. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 248. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2017-2032 (USD MILLION)
TABLE 249. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2017-2032 (USD MILLION)
TABLE 250. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 251. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 252. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2017-2032 (USD MILLION)
TABLE 253. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2017-2032 (USD MILLION)
TABLE 254. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 255. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 256. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2017-2032 (USD MILLION)
TABLE 257. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2017-2032 (USD MILLION)
TABLE 258. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 259. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 260. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 261. AFRICA DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2017-2032 (USD MILLION)
TABLE 262. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 263. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 264. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 265. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2017-2032 (USD MILLION)
TABLE 266. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 267. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2017-2032 (USD MILLION)
TABLE 268. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2017-2032 (USD MILLION)
TABLE 269. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 270. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 271. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2017-2032 (USD MILLION)
TABLE 272. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2017-2032 (USD MILLION)
TABLE 273. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 274. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 275. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2017-2032 (USD MILLION)
TABLE 276. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2017-2032 (USD MILLION)
TABLE 277. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 278. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 279. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 280. ASEAN DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2017-2032 (USD MILLION)
TABLE 281. GCC DIABETES CARE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 282. GCC DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 283. GCC DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2017-2032 (USD MILLION)
TABLE 284. GCC DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 285. GCC DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2017-2032 (USD MILLION)
TABLE 286. GCC DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2017-2032 (USD MILLION)
TABLE 287. GCC DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 288. GCC DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 289. GCC DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2017-2032 (USD MILLION)
TABLE 290. GCC DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2017-2032 (USD MILLION)
TABLE 291. GCC DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 292. GCC DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 293. GCC DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2017-2032 (USD MILLION)
TABLE 294. GCC DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2017-2032 (USD MILLION)
TABLE 295. GCC DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 296. GCC DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 297. GCC DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 298. GCC DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2017-2032 (USD MILLION)
TABLE 299. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 300. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 301. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2017-2032 (USD MILLION)
TABLE 302. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 303. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2017-2032 (USD MILLION)
TABLE 304. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2017-2032 (USD MILLION)
TABLE 305. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 306. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 307. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2017-2032 (USD MILLION)
TABLE 308. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2017-2032 (USD MILLION)
TABLE 309. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 310. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 311. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2017-2032 (USD MILLION)
TABLE 312. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2017-2032 (USD MILLION)
TABLE 313. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 314. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 315. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 316. EUROPEAN UNION DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2017-2032 (USD MILLION)
TABLE 317. BRICS DIABETES CARE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 318. BRICS DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 319. BRICS DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2017-2032 (USD MILLION)
TABLE 320. BRICS DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 321. BRICS DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2017-2032 (USD MILLION)
TABLE 322. BRICS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2017-2032 (USD MILLION)
TABLE 323. BRICS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 324. BRICS DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 325. BRICS DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2017-2032 (USD MILLION)
TABLE 326. BRICS DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2017-2032 (USD MILLION)
TABLE 327. BRICS DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 328. BRICS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 329. BRICS DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2017-2032 (USD MILLION)
TABLE 330. BRICS DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2017-2032 (USD MILLION)
TABLE 331. BRICS DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 332. BRICS DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 333. BRICS DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 334. BRICS DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2017-2032 (USD MILLION)
TABLE 335. G7 DIABETES CARE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 336. G7 DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 337. G7 DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2017-2032 (USD MILLION)
TABLE 338. G7 DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2017-2032 (USD MILLION)
TABLE 339. G7 DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2017-2032 (USD MILLION)
TABLE 340. G7 DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2017-2032 (USD MILLION)
TABLE 341. G7 DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2017-2032 (USD MILLION)
TABLE 342. G7 DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 343. G7 DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2017-2032 (USD MILLION)
TABLE 344. G7 DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2017-2032 (USD MILLION)
TABLE 345. G7 DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 346. G7 DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2017-2032 (USD MILLION)
TABLE 347. G7 DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2017-2032 (USD MILLION)
TABLE 348. G7 DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2017-2032 (USD MILLION)
TABLE 349. G7 DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 350. G7 DIABETES CARE DEVICES MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 351. G7 DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 352. G7 DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2017-2032 (USD MILLION)
TABLE 353. NATO DIABETES CARE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 354. NATO DIABETES CARE DEVICES MARKET SIZE, BY DEVI

Companies Mentioned

  • Abbott Laboratories
  • Acon Laboratories Inc.
  • ARKray Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG
  • Becton Dickinson and Company BD
  • Bionime Corporation
  • Dexcom Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Insulet Corporation
  • LifeScan Inc.
  • Medtronic plc
  • Menarini Diagnostics
  • MicroTech Medical Inc.
  • Nipro Corporation
  • Novo Nordisk A/S
  • Sanofi
  • Senseonics Holdings Inc.
  • Sinocare
  • Tandem Diabetes Care Inc.
  • Terumo Corporation
  • Trividia Health
  • Valeritas Holdings Inc.
  • Ypsomed Holding AG

Table Information

Report AttributeDetails
No. of Pages188
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 36.34 Billion
Forecasted Market Value ( USD ) by 2032 $ 77.72 Billion
Compound Annual Growth Rate13.4%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Diabetes Care Devices - Global Strategic Business Report - Product Image

Diabetes Care Devices - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Diabetes Care Devices Market by Product Type (Blood Glucose Monitoring (CGM), Insulin Delivery Devices (Insulin Pumps (Tethered), Insulin Pens, Pen Needles), Application) Disease Type (Type 1, Type 2), End User (Homecare/Self) - Global Forecast to 2030 - Product Image

Diabetes Care Devices Market by Product Type (Blood Glucose Monitoring (CGM), Insulin Delivery Devices (Insulin Pumps (Tethered), Insulin Pens, Pen Needles), Application) Disease Type (Type 1, Type 2), End User (Homecare/Self) - Global Forecast to 2030

  • Report
  • 304 Pages
  • Global
From
Diabetes Care Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Image

Diabetes Care Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Report
  • 150 Pages
  • Global
From
Diabetes Care Devices Market Size, Share, Trends and Forecast by Type, Distribution Channel, End User, and Region, 2026-2034 - Product Image

Diabetes Care Devices Market Size, Share, Trends and Forecast by Type, Distribution Channel, End User, and Region, 2026-2034

  • Report
  • 137 Pages
  • Global
From
Diabetes Care Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025-2033 - Product Image

Diabetes Care Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025-2033

  • Report
  • 189 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.